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A
lthough physical activity (PA) is a
key element in the prevention and
management of type 2 diabetes,
many with this chronic disease do not
become or remain regularly active.
High-quality studies establishing the
importance of exercise and ﬁtness in di-
abetes were lacking until recently, but it
is now well established that participa-
tion in regular PA improves blood glu-
cose control and can prevent or delay
type 2 diabetes, along with positively
impacting lipids, blood pressure, car-
diovascular events, mortality, and qual-
ity of life. Structured interventions
combining PA and modest weight loss
have been shown to lower risk of type 2
diabetes by up to 58% in high-risk pop-
ulations. Most beneﬁts of PA on diabe-
tes management are realized through
acute and chronic improvements in in-
sulin action, accomplished with both
aerobic and resistance training. The
beneﬁts of physical training are dis-
cussed, along with recommendations
for varying activities, PA-associated
blood glucose management, diabetes
prevention, gestational diabetes melli-
tus, and safe and effective prac-
tices for PA with diabetes-related
complications.
Diabetes has become a widespread
epidemic, primarily due to increasing
prevalence and incidence of type 2 dia-
betes. According to the Centers for Dis-
ease Control and Prevention, in 2007
almost 24 million Americans had diabe-
tes, with one-quarter of those, or six
million, undiagnosed (1). Currently, it
is estimated that almost 60 million U.S.
residents also have prediabetes—a con-
dition in which blood glucose levels are
above normal—thus greatly increasing
theirriskoftype2diabetes(1).Lifetime
risk estimates suggest that one in three
Americans born in 2000 or later will
develop diabetes, but in high-risk eth-
nic populations, closer to 50% may de-
velop it (2). Diabetes is a signiﬁcant
cause of premature mortality and mor-
bidity related to cardiovascular disease,
blindness, kidney and nerve disease,
and amputation (1). Although regular
PAmaypreventordelaydiabetesandits
complications (3–10), the majority of
people with type 2 diabetes are not ac-
tive (11).
In this article, the broader term
“physical activity” (deﬁned as bodily
movement produced by the contraction
of skeletal muscle that substantially in-
creases energy expenditure) is used in-
terchangeably with “exercise,” which is
deﬁned as a subset of PA done with the
intention of developing physical ﬁtness
(i.e., cardiovascular, strength, and ﬂex-
ibility training). The intent is to recog-
nize that many types of physical
movement may have a positive impact
on physical ﬁtness, morbidity, and
mortality in individuals with type 2
diabetes.
Conclusion
Exercise plays a major role in the preven-
tionandcontrolofinsulinresistance,pre-
diabetes, gestational diabetes mellitus,
type 2 diabetes, and diabetes-related
health complications. Both aerobic train-
ing and resistance training improve insu-
lin action, at least acutely, and can assist
withmanagementofbloodglucoselevels,
lipids, blood pressure, cardiovascular
risk, mortality, and quality of life, but ex-
ercise must be undertaken regularly to
have continued beneﬁts and likely in-
clude regular training of varying types.
Most people with type 2 diabetes can per-
form exercise safely, as long as certain
precautionsaretaken.Theinclusionofan
exercise program or other means of in-
creasing overall PA is critical for optimal
healthinindividualswithtype2diabetes.
Both the American College of
Sports Medicine (ACSM) and the Amer-
ican Diabetes Association (ADA) re-
viewed the relevant, published research
and developed the recommendations
that are deﬁned in Table 1 and listed in
Table 2. The entire position statement
can be accessed online at http://care.
diabetesjournals.org.
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I. ACSM evidence categories
Evidence
category Source of evidence Deﬁnition
A Randomized, controlled trials (overwhelming data) Provides a consistent pattern of ﬁndings with substantial studies
B Randomized, controlled trials (limited data) Few randomized trials exist, which are small in size, and results are
inconsistent
C Nonrandomized trials, observational studies Outcomes are from uncontrolled, nonrandomized, and/or observational
studies
D Panel consensus judgment Panel’s expert opinion when the evidence is insufﬁcient to place it in
categories A through C
II. ADA evidence-grading system for clinical practice recommendations
Level of
evidence Description
A Clear evidence from well-conducted, generalizable, randomized, controlled trials that are adequately powered, including the
following:
• Evidence from a well-conducted multicenter trial
• Evidence from a meta-analysis that incorporated quality ratings in the analysis
Compelling nonexperimental evidence, i.e., the “all-or-none” rule developed by the Centre for Evidence-Based Medicine at Oxford
Supportive evidence from well-conducted, randomized, controlled trials that are adequately powered, including the following:
• Evidence from a well-conducted trial at one or more institutions
• Evidence from a meta-analysis that incorporated quality ratings in the analysis
B Supportive evidence from well-conducted cohort studies, including the following:
• Evidence from a well-conducted prospective cohort study or registry
• Evidence from a well-conducted meta-analysis of cohort studies
Supportive evidence from a well-conducted case-control study
C Supportive evidence from poorly controlled or uncontrolled studies, including the following:
• Evidence from randomized clinical trials with one or more major or three or more minor methodological ﬂaws that could
invalidate the results
• Evidence from observational studies with high potential for bias (such as case series with comparison to historical controls)
• Evidence from case series or case reports
Conﬂicting evidence with the weight of evidence supporting the recommendation
E Expert consensus or clinical experience
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ACSM evidence and ADA clinical practice recommendation statements
ACSM evidence category
(A, highest; D, lowest)/
ADA level of evidence
(A, highest; E, lowest)
Acute effects of exercise • PA causes increased glucose uptake into active muscles balanced by hepatic
glucose production, with a greater reliance on carbohydrate to fuel
muscular activity as intensity increases.
A/*
• Insulin-stimulated blood glucose uptake into skeletal muscle predominates
at rest and is impaired in type 2 diabetes, while muscular contractions
stimulate blood glucose transport via a separate, additive mechanism not
impaired by insulin resistance or type 2 diabetes.
A/*
• Although moderate aerobic exercise improves blood glucose and insulin
action acutely, the risk of exercise-induced hypoglycemia is minimal
without use of exogenous insulin or insulin secretagogues. Transient
hyperglycemia can follow intense PA.
C/*
• The acute effects of resistance exercise in type 2 diabetes have not been
reported, but result in lower fasting blood glucose levels for at least 24 h
postexercise in individuals with impaired fasting glucose.
C/*
• A combination of aerobic and resistance exercise training may be more
effective in improving blood glucose control than either alone; however,
more studies are needed to determine whether total caloric expenditure,
exercise duration, or exercise mode is responsible.
B/*
• Milder forms of exercise (e.g., tai chi, yoga) have shown mixed results. C/*
• PA can result in acute improvements in systemic insulin action lasting from
2t o7 2h .
A/*
Chronic effects of exercise
training
• Both aerobic and resistance training improve insulin action, blood glucose
control, and fat oxidation and storage in muscle.
B/*
• Resistance exercise enhances skeletal muscle mass. A/*
• Blood lipid responses to training are mixed but may result in a small
reduction in LDL cholesterol with no change in HDL cholesterol or
triglycerides. Combined weight loss and PA may be more effective than
aerobic exercise training alone on lipids.
C/*
• Aerobic training may slightly reduce systolic blood pressure, but reductions
in diastolic blood pressure are less common, in individuals with type 2
diabetes.
C/*
• Observational studies suggest that greater PA and ﬁtness are associated with
a lower risk of all-cause and cardiovascular mortality.
C/*
• Recommended levels of PA may help produce weight loss. However, up to
60 min/day may be required when relying on exercise alone for weight loss.
C/*
• Individuals with type 2 diabetes engaged in supervised training exhibit
greater compliance and blood glucose control than those undertaking
exercise training without supervision.
B/*
• Increased PA and physical ﬁtness can reduce symptoms of depression and
improve health-related quality of life in those with type 2 diabetes.
B/*
PA and prevention of type 2
diabetes
• At least 2.5 h/week of moderate to vigorous PA should be undertaken as
part of lifestyle changes to prevent type 2 diabetes onset in high-risk adults.
A/A
PA in prevention and control of
gestational diabetes mellitus
• Epidemiological studies suggest that higher levels of PA may reduce risk of
developing gestational diabetes mellitus during pregnancy.
C/*
• Randomized controlled trials suggest that moderate exercise may lower
maternal blood glucose levels in gestational diabetes mellitus.
B/*
Preexercise evaluation • Before undertaking exercise more intense than brisk walking, sedentary
persons with type 2 diabetes will likely beneﬁt from an evaluation by a
physician. Electrocardiogram exercise stress testing for asymptomatic
individuals at low risk of coronary artery disease is not recommended but
may be indicated for higher risk.
C/C
(continued)
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ACSM evidence and ADA clinical practice recommendation statements
ACSM evidence category
(A, highest; D, lowest)/
ADA level of evidence
(A, highest; E, lowest)
Recommended PA participation
for persons with type 2
diabetes
• Persons with type 2 diabetes should undertake at least 150 min/week of
moderate to vigorous aerobic exercise spread out over at least 3 days
during the week, with no more than 2 consecutive days between bouts of
aerobic activity.
B/B
• In addition to aerobic training, persons with type 2 diabetes should
undertake moderate to vigorous resistance training at least 2–3 days/week.
B/B
• Supervised and combined aerobic and resistance training may confer
additional health beneﬁts, although milder forms of PA (such as yoga) have
shown mixed results. Persons with type 2 diabetes are encouraged to
increase their total daily unstructured PA. Flexibility training may be
included but should not be undertaken in place of other recommended
types of PA.
B/C
Exercise with nonoptimal
blood glucose control
• Individuals with type 2 diabetes may engage in PA, using caution when
exercising with blood glucose levels exceeding 300 mg/dl (16.7 mmol/l)
without ketosis, provided they are feeling well and are adequately
hydrated.
C/E
• Persons with type 2 diabetes not using insulin or insulin secretagogues are
unlikely to experience hypoglycemia related to PA. Users of insulin and
insulin secretagogues are advised to supplement with carbohydrate as
needed to prevent hypoglycemia during and after exercise.
C/C
Medication effects on exercise
responses
• Medication dosage adjustments to prevent exercise-associated
hypoglycemia may be required by individuals using insulin or certain
insulin secretagogues. Most other medications prescribed for concomitant
health problems do not affect exercise, with the exception of -blockers,
some diuretics, and statins.
C/C
Exercise with long-term
complications of diabetes
• Known cardiovascular disease is not an absolute contraindication to
exercise. Individuals with angina classiﬁed as moderate or high risk should
likely begin exercise in a supervised cardiac rehabilitation program. PA is
advised for anyone with peripheral artery disease.
C/C
• Individuals with peripheral neuropathy and without acute ulceration may
participate in moderate weight-bearing exercise. Comprehensive foot care
including daily inspection of feet and use of proper footwear is
recommended for prevention and early detection of sores or ulcers.
Moderate walking likely does not increase risk of foot ulcers or re-
ulceration with peripheral neuropathy.
B/B
• Individuals with cardiac autonomic neuropathy should be screened and
receive physician approval and possibly an exercise stress test prior to
exercise initiation. Exercise intensity is best prescribed using the heart rate
reserve method with direct measurement of maximal heart rate.
C/C
• Individuals with uncontrolled proliferative retinopathy should avoid
activities that greatly increase intraocular pressure and hemorrhage risk.
D/E
• Exercise training increases physical function and quality of life in
individuals with kidney disease and may even be undertaken during
dialysis sessions. The presence of microabuminuria per se does not
necessitate exercise restrictions.
C/C
Adoption and maintenance of
exercise by persons with
diabetes
• Efforts to promote PA should focus on developing self-efﬁcacy and
fostering social support from family, friends, and health care providers.
Encouraging mild or moderate PA may be most beneﬁcial to adoption and
maintenance of regular PA participation. Lifestyle interventions may have
some efﬁcacy in promoting PA behavior.
B/B
*No recommendation given.
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